Anti-nociceptive effect of duloxetine in mouse model of diabetic neuropathic pain

Indian Journal of Experimental Biology

Volumn 47, Issue 3, 2009, Pages 193-197

  Kuhad, Anurag ^a   Bishnoi, Mahendra ^a   Chopra, Kanwaljit ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

Adenosine; Diabetes; Duloxetine; Neuropathy

Indexed keywords

MUS;

ADENOSINE; DULOXETINE; SEROTONIN UPTAKE INHIBITOR; STREPTOZOCIN; THIOPHENE DERIVATIVE;

ANIMAL; ARTICLE; BRAIN CORTEX; DIABETIC NEUROPATHY; DOSE RESPONSE; DRUG EFFECT; EXPERIMENTAL DIABETES MELLITUS; HEAT; HYPERALGESIA; MALE; METABOLISM; MOUSE; MOUSE STRAIN; PAIN ASSESSMENT; PAIN THRESHOLD; TOUCH;

ADENOSINE; ANIMALS; CEREBRAL CORTEX; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEUROPATHIES; DOSE-RESPONSE RELATIONSHIP, DRUG; HOT TEMPERATURE; HYPERALGESIA; MALE; MICE; MICE, INBRED STRAINS; PAIN MEASUREMENT; PAIN THRESHOLD; SEROTONIN UPTAKE INHIBITORS; STREPTOZOCIN; THIOPHENES; TOUCH;

EID: 65549124387     PISSN: 00195189     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Said G, Diabetic neuropathya review, Nat Clin Pract Neurol, 3 (2007) 331.
2. Pop-Busui R, Sima A and Stevens M, Diabetic neuropathy and oxidative stress. Diabetes Metab Res Rev, 22 (2006) 257.
3. (Pubitemid 46053392) Nicholson S, The effect of cost sharing on employees with diabetes. Am J. Manag Care, 12 (2006) SP20.
4. Edwards J. L, Vincent A M, Cheng H T and Feldman E L, Diabetic neuropathy: Mechanisms to management, Pharmacol Ther, 120 (2008) 1.
5. (Pubitemid 43993105) Gidal B E and Billington R, New and emerging treatment options for neuropathic pain, Am J. Manag Care, 12 (2006) S269.
6. Vinik A I, Maser R E, Mitchell B D and Freeman R, Diabetic autonomic neuropathy, Diabetes Care, 26 (2003) 1553.
7. Greene D A, Lattimer S A and Sima A A F, Sorbitol phosphoinositol and sodium-potassium-ATPase in the pathologies of diabetic complications, N Engl J. Med, 316 (1987) 599.
8. (Pubitemid 40208261) Bomholt S F, Mikkelsen J. D and Blackburn-Munro G, Antinociceptive effects of the antidepressants amitriptyline, duloxetine, mirtazapine and citalopram in animal models of acute, persistent and neuropathic pain, Neuropharmacology, 48 (2005) 252.
9. Sawynok J. and Sweeney M I, The role of purines in nociception, Neurosciences, 32 (1989) 557.
10. Guieu R, Peragut J. C, Roussel P, Hassani H, Sampieri F, Bechis G, Gola R and Rochat H, Adenosine and neuropathic pain, Pain, 68 (1996) 271.
11. (Pubitemid 34804728) Ulugol A, Karadag H C, Tamer M, Firat Z, Aslantas A and Dokmeci I, Involvement of adenosine in the anti-allodynic effect of amitriptyline in streptozotocin-induced diabetic rats, Neurosci Lett, 328 (2002) 129.
12. Wong D T and Bymaster F P, Dual serotonin and noradrenaline uptake inhibitor class of antidepressants: potential for greater efficacy or just hype, Prog Drug Res, 58 (2002) 169.
13. (Pubitemid 35254112) Detke M J, Lu Y, Goldstein D J, McNamara R K and Demitrack M A, Duloxetine 60 mg once daily dosing versus placebo in the acute treatment of major depression, J. Psychiatr Res, 36 (2002) 383.
14. (Pubitemid 34456358) Detke M J, Lu Y, Goldstein D J, Hayes J. R&Demitrack M A, Duloxetine, 60 mg once daily, for major depressive disorder: a randomized double-blind placebo controlled trial, J. Clin Psychiatr, 63 (2002) 308.
15. Goldstein D J, Mallinckrodt C H, Lu Y and Demitrack M A, Duloxetine in the treatment of major depressive disorder: a double-blind clinical trial, J. Clin Psychiatr, 63 (2002) 225.
16. Goldstein D J, Lu Y and Detke M J, Effects of duloxetine on painful physical symptoms associated with depression, Psychosomatics, 45 (2004) 17.
17. Iyengar S, Detke M and Ahmad L J, Efficacy of the selective serotonin and norepinephrine reuptake inhibitor, duloxetine, in the formalin model of persistent pain, Eur Neuropsycho, 12 (2002) S43.
18. Goldstein D J, Lu Y and Detke M J, Duloxetine vs. placebo in patients with painful diabetic neuropathy, Pain, 116 (2005) 109.
19. Jones C K, Peters S C and Shannon H E, Efficacy of duloxetine, a potent and balanced and noradrenergic reuptake inhibitor, in inflammatory acute pain models in rodents. JPET 312 (2005) 726.
20. (Pubitemid 351615310) Kuhad A, Sharma S and Chopra K, Lycopene attenuates thermal hyperalgesia in a diabetic mouse model of neuropathic pain, Eur J. Pain, 12 (2008) 624.
21. (Pubitemid 19040156) Ramabadran K, Bansinath M, Turndorf H and Puig M M, The hyperalgesic effect of naloxone is attenuated in streptozotocin induced diabetic mice, Psychopharmacology, 97 (1989) 169.
22. Kannan S A, Saade N E, Haddad J. J, Abdelnoor A M, Atweh S F, Jabbur S J. and Garabelian B S, Endotoxin induced local inflammation and hyperalgesia in rats mince, a new model for inflammatory pain, Pharmacol, 66 (1996) 373.
23. Phillis J. W, Simpson R E and Walter G A, The effect of hyperglycemia on extracellular levels of adenosine in the hypoxic rat cerebral cortex, Brain Res, 524 (1990) 336.
24. Poon A and Sawynok J, Antinociception by adenosine analogs and an adenosine kinase inhibitor: dependence on formalin concentration, Eur J. Pharmacol, 286 (1995) 177.
25. Lavand'homme P M and Eisenach J. C, Exogenous and endogenous adenosine enhance the spinal antiallodynic effects of morphine in a rat model of neuropathic pain, Pain, 80 (1999) 31.
26. Segerdahl M and Sollevi A, Adenosine and pain relief: a clinical overview, Drug Dev Res, 45 (1998) 151.
27. Zhu C Z, Mikusa J, Chu K L, Cowart M, Kowaluk E A and Jarvis M F, A134974: A novel adenosine kinase inhibitor relieves tactile allodynia via spinal sites if action in peripheral nerve injured rats, Brain Res, 905 (2001) 104.
28. Lynch J. J, Jarvis M F and Kowaluck E A, An adenosine kinase inhibition attenuates tactile allodynia in rat model of diabetic neuropathic pain, Eur J. Pharmacol, 364 (1999) 141.
29. Zhou J. G, Meno J. R, Hsu S S and Winn H R, Effects of theophylline and cyclohexyladenosine on brain injury following normoand hyper-glycemic ischemia: A histopathologic study in the rat, J. Cereb Blood Flow Metab, 14 (1994) 166.
30. Saini A K, Arun K H S, Kaul C L and Sharma S S, Acute hyperglycemia attenuates nerve conduction velocity and nerve blood flow in male Sprague-Dawley rats: reversal by adenosine, Pharmacol Res, 50 (2004) 593.
31. (Pubitemid 17199745) Sollevi A, Cardiovascular effects of adenosine in man; possible clinical implications, Prog Neurobiol, 27 (1986) 319.